apomorphine has been researched along with fenoldopam in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (16.67) | 18.7374 |
1990's | 5 (41.67) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flaim, KE; Gessner, GW; Ladd, DL; Sawyer, JL; Weinstock, J; Wise, M | 1 |
Caron, MG; Tiberi, M | 1 |
Brusniak, MY; Neve, KA; Pearlman, RS; Wilcox, RE | 1 |
Brusniak, MY; DuRand, CJ; Huang, WH; Neve, KA; Pearlman, RS; Teeter, MM; Wiens, BL; Wilcox, DM; Wilcox, RE | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Demenge, P; Pellissier, G | 1 |
Amenta, F; Cavallotti, C; Collier, WL; De Michele, M; Ricci, A | 1 |
Martinez-Mir, I; Morales-Olivas, FJ; Rubio, E | 1 |
Giambalvo, CT; Wagner, RL | 1 |
Ng, SS; Pang, CC | 1 |
Bravo, G; Centurión, D; Ramírez-San Juan, E; Sánchez-López, A; Saxena, PR; Villalón, CM; Willems, EW | 1 |
1 review(s) available for apomorphine and fenoldopam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for apomorphine and fenoldopam
Article | Year |
---|---|
Synthesis and dopaminergic binding of 2-aryldopamine analogues: phenethylamines, 3-benzazepines, and 9-(aminomethyl)fluorenes.
Topics: Animals; Apomorphine; Benzazepines; Cattle; Fluorenes; In Vitro Techniques; Molecular Conformation; Phenethylamines; Receptors, Dopamine; Structure-Activity Relationship | 1986 |
High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Apomorphine; Benzazepines; Brain; Butaclamol; Cell Line; Cell Membrane; Cyclic AMP; Dopamine; Dose-Response Relationship, Drug; Embryo, Mammalian; Fenoldopam; Flupenthixol; Genomic Library; GTP-Binding Proteins; Humans; Kidney; Kinetics; Rats; Receptors, Dopamine D1; Transfection | 1994 |
Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors.
Topics: Animals; Cell Line; Chlorocebus aethiops; Computer Graphics; Dopamine; Dopamine Agonists; Glioma; Humans; Kinetics; Models, Molecular; Receptors, Dopamine D1; Recombinant Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 1996 |
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.
Topics: Alanine; Amino Acid Substitution; Animals; Bromocriptine; Combinatorial Chemistry Techniques; Dopamine Agonists; Models, Molecular; Pergolide; Point Mutation; Radioligand Assay; Rats; Receptors, Dopamine D2; Recombinant Proteins; Serine; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia; Animals; Antipsychotic Agents; Apomorphine; Benzamides; Benzazepines; Blood Pressure; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Fenoldopam; Heart Rate; Injections, Spinal; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Spinal Cord | 1991 |
Age-related changes of dopamine sensitive cyclic AMP generation in the rat frontal cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Animals; Apomorphine; Benzazepines; Bromocriptine; Cyclic AMP; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Fenoldopam; Frontal Lobe; Male; Quinpirole; Rats; Rats, Inbred Strains | 1990 |
The lack of the effect of DA-1 and DA-2 dopamine agonists on the isolated guinea-pig atria.
Topics: Animals; Apomorphine; Benzazepines; Bromocriptine; Domperidone; Electric Stimulation; Female; Fenoldopam; Guinea Pigs; Heart; In Vitro Techniques; Male; Piribedil; Propranolol; Receptors, Dopamine; Vasodilator Agents | 1987 |
Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Calcium; Corpus Striatum; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Activation; Ergolines; Fenoldopam; Male; Phenethylamines; Protein Kinase C; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Synaptosomes; Tetrodotoxin | 1994 |
In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist.
Topics: Animals; Apomorphine; Blood Pressure; Cardiac Output; Dopamine Agonists; Dose-Response Relationship, Drug; Fenoldopam; Ganglionic Blockers; Male; Mecamylamine; Pressoreceptors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Vascular Resistance; Vasodilator Agents | 2000 |
Pharmacological profile of the vascular responses to dopamine in the canine external carotid circulation.
Topics: Animals; Apomorphine; Benzazepines; Blood Pressure; Bromocriptine; Carotid Artery, External; Dogs; Dopamine; Dopamine Agonists; Dopamine Antagonists; Fenoldopam; Haloperidol; Heart Rate; Male; Tyramine; Vagotomy; Vasoconstrictor Agents; Vasodilator Agents | 2003 |